Kates R - Search Results

1

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.

Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N. Nitz UA, et al. Among authors: kates r. Ann Oncol. 2017 Nov 1;28(11):2768-2772. doi: 10.1093/annonc/mdx494. Ann Oncol. 2017. PMID: 28945833 Free article. Clinical Trial.

2

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up.

Harbeck N, Dettmar P, Thomssen C, Berger U, Ulm K, Kates R, Höfler H, Jänicke F, Graeff H, Schmitt M. Harbeck N, et al. Among authors: kates r. Br J Cancer. 1999 May;80(3-4):419-26. doi: 10.1038/sj.bjc.6690373. Br J Cancer. 1999. PMID: 10408848 Free PMC article.

3

Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer.

Harbeck N, Alt U, Berger U, Kates R, Krüger A, Thomssen C, Jänicke F, Graeff H, Schmitt M. Harbeck N, et al. Among authors: kates r. Int J Biol Markers. 2000 Jan-Mar;15(1):79-83. doi: 10.1177/172460080001500115. Int J Biol Markers. 2000. PMID: 10763146 Free article.

4

Neural network analysis of follow-up data in primary breast cancer.

Harbeck N, Kates R, Ulm K, Graeff H, Schmitt M. Harbeck N, et al. Among authors: kates r. Int J Biol Markers. 2000 Jan-Mar;15(1):116-22. doi: 10.1177/172460080001500123. Int J Biol Markers. 2000. PMID: 10763154 Free article.

5

Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.

Harbeck N, Alt U, Berger U, Krüger A, Thomssen C, Jänicke F, Höfler H, Kates RE, Schmitt M. Harbeck N, et al. Among authors: kates re. Clin Cancer Res. 2001 Sep;7(9):2757-64. Clin Cancer Res. 2001. PMID: 11555589

6

Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination.

Harbeck N, Kates RE, Schmitt M. Harbeck N, et al. J Clin Oncol. 2002 Feb 15;20(4):1000-7. doi: 10.1200/JCO.2002.20.4.1000. J Clin Oncol. 2002. PMID: 11844823

7

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

Harbeck N, Kates RE, Look MP, Meijer-Van Gelder ME, Klijn JG, Krüger A, Kiechle M, Jänicke F, Schmitt M, Foekens JA. Harbeck N, et al. Cancer Res. 2002 Aug 15;62(16):4617-22. Cancer Res. 2002. PMID: 12183417

8

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

9

Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

Zemzoum I, Kates RE, Ross JS, Dettmar P, Dutta M, Henrichs C, Yurdseven S, Höfler H, Kiechle M, Schmitt M, Harbeck N. Zemzoum I, et al. J Clin Oncol. 2003 Mar 15;21(6):1022-8. doi: 10.1200/JCO.2003.04.170. J Clin Oncol. 2003. PMID: 12637466

10

Advanced statistical methods for the definition of new staging models.

Kates R, Schmitt M, Harbeck N. Kates R, et al. Recent Results Cancer Res. 2003;162:101-13. doi: 10.1007/978-3-642-59349-9_9. Recent Results Cancer Res. 2003. PMID: 12790325 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page